Network Structure of Depression and Anxiety Symptoms in Older Asian Patients With Depressive Disorders: Findings From REAP-AD3

Article information

Psychiatry Investig. 2025;22(5):552-563
Publication date (electronic) : 2025 May 15
doi : https://doi.org/10.30773/pi.2025.0033
1Department of Psychiatry, Hanyang University College of Medicine, Seoul, Republic of Korea
2Department of Psychiatry, Hanyang University Guri Hospital, Guri, Republic of Korea
3Hanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul, Republic of Korea
4Workplace Mental Health Institute, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
5Department of Psychology, Ajou University, Suwon, Republic of Korea
6The School of Human Sciences, Texas Women’s University, Denton, TX, United States
7Department of Premedicine, Hanyang University College of Medicine, Seoul, Republic of Korea
8Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Centre for Mental Disorders (Peking University Sixth Hospital), Beijing, China
9Pushpagiri Institute of Medical Sciences and Research Centre, Thiruvalla and Mar Sleeva Medicity, Palai, India
10Department of Psychiatry, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
11Mental Health Research Centre, Psychosocial Health Research Institute, Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
12Department of Psychiatry & Mental Health, Tunku Abdul Rahman Institute of Neurosciences, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia
13Pakistan Psychiatric Research Centre, Fountain House, Lahore, Pakistan
14Institute of Mental Health, Buangkok Green Medical Park, Singapore
15Department of Psychiatry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
16Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
17Department of Psychiatry, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan
18Taipei City Hospital and Psychiatric Centre, Taipei, Taiwan
19School of Human Sciences, Seinan Gakuin University, Fukuoka, Japan
20Association for the Improvement of Mental Health Programs, Geneva, Switzerland
Correspondence: Seon-Cheol Park, MD, PhD Department of Psychiatry, Hanyang University Guri Hospital, 153 Gyeongchun-ro, Guri 11923, Republic of Korea Tel: +82-31-560-5273, Fax: +82-31-554-5599, E-mail: psc76@hanyang.ac.kr
Received 2025 January 23; Revised 2025 February 10; Accepted 2025 February 24.

Abstract

Objective

The clinical presentation of depressive disorders might be influenced by age, and its diagnosis and treatment can be affected by ageism-related bias. A network analysis can reveal symptom patterns unrecognized by the reductionistic approach. Therefore, this study explores the network structure of depression and anxiety symptoms in older Asian patients with depressive disorders and examines age-related differences in the context of ageism.

Methods

We used data from the Research on Asian Psychotropic Prescription Patterns for Antidepressants, Phase 3 study and included 2,785 psychiatric patients from 11 Asian countries. Depression and anxiety symptoms were assessed using the Patient Health Questionnaire-9 and Generalized Anxiety Disorder-7. Network analyses were conducted to identify symptom interconnections and centrality among older (>65 years), middle-aged (35–64 years), and young (18–34 years) adult groups. The network structures were also compared using a network comparison test.

Results

Depressed mood was the most central symptom across all age groups. Network comparisons revealed no significant structural differences among the three age groups, despite several variations in terms of global strength. The network structure of the older group was characterized by strong interconnections between somatic symptoms (insomnia-energy) and core depressive symptoms (little interest or pleasure-feelings of hopelessness).

Conclusion

This study reveals that the network structures of depression and anxiety symptoms have relatively consistent interconnections across age groups, despite subtle age-based differences. Specifically, older adults tend to present anxiety and depression symptoms as physical complaints. These findings challenge ageist stereotypes and advocate for inclusive, age-neutral approaches to treatment.

INTRODUCTION

Depressive disorders are a major public mental health issue worldwide [1-3]. Many subtypes of depressive disorders have been defined because of heterogeneous symptoms [4], and age might be an influential factor in the clinical presentation and classification of these disorders. However, inconsistencies in agerelated features have been reported in several previous studies [5]. Notably, the severity of depression tends to be lower in older individuals than in younger individuals. In terms of specific symptoms, younger patients are characterized by severe suicidal ideation, guilt, and irritability, whereas older patients predominantly exhibit somatic symptoms such as illness anxiety and insomnia, particularly early morning awakening [6-9]. The pervasive influence of ageism necessitates a critical evaluation of its impact on the perception and treatment of depression and aging. Ageism, which affects both older and younger populations, denotes stereotypes, prejudices, and discrimination based on age. In terms of depressive disorders, older adults are often perceived as frail or dependent, which contributes to their marginalization in mental health care and research. Conversely, younger individuals with depressive disorders are frequently regarded as impulsive or irresponsible. Such biases can exacerbate care inequities and reinforce internalized societal stereotypes, manifesting as self-perceived ageism that further influences the mental health outcomes of patients [10-12].

A recent neuroimaging study on age-related changes in brain networks supports the complexity of depression manifestations across the lifespan. In older adults, structural connectivity exhibits compensatory reorganization in response to cognitive function decline, taking advantage of the redundant mechanisms in large-scale brain networks. It has been suggested that these networks can provide alternative pathways for information processing. In addition, they could be protected by factors that mitigate age-related changes, particularly in areas associated with cognitive control and default mode activity [13]. These compensatory processes align with the age-associated clinical features of depressive disorders. In addition, anxiety symptoms are closely associated with depression symptoms and might influence the network structure of depression symptoms in patients with depressive disorders [14]. Network analysis can reveal symptom patterns unrecognized by conventional reductionistic approaches because it is a bottom-up approach. Thus, this study uses data from the Research on Asian Psychotropic Prescription Patterns for Antidepressants, Phase 3 (REAP-AD3) study to compare the network structures of depression and anxiety symptoms among older (>65 years), middle-aged (35–64 years), and young adult (18–34 years) Asian patients with depressive disorders [15,16]. Specifically, this study characterizes the network structure of older Asian patients with depressive disorders in the context of ageism.

METHODS

Study participants

The REAP-AD3 study, conducted from August 2023 to February 2024 across 11 Asian countries (China, India, Indonesia, Iran, Japan, Korea, Malaysia, Pakistan, Singapore, Taiwan, and Thailand), was a large-scale research project that enrolled 4,587 psychiatric patients receiving antidepressant treatment. In the REAP-AD3 study, participants were selected based on their antidepressant use. Ethical reviews of the study protocol were conducted, and informed consent forms were collected and approved by the institutional review boards of all study centers, including Hanyang University Guri Hospital in Guri, Republic of Korea (receipt number: 2023-05-021-006). All participants provided written informed consent for their data to be used for research purposes. Coordinated by the REAP consortium, data collection was securely managed via a web-based platform hosted by Taipei City Hospital.

The inclusion criteria for this study were as follows: 1) a diagnosis of depressive disorder, such as depressive episode (F32), recurrent depressive disorder (F33), or persistent depressive disorder (F34), according to the International Classification of Diseases, tenth edition [17], as determined by clinical psychiatrists; 2) the use of at least one antidepressant classified under the Anatomical Therapeutic Chemical classification system [18]; and 3) age of at least 18 years. The exclusion criteria were as follows: 1) severe medical or neurological conditions, 2) inability to provide informed consent, and 3) age less than 10 years. Using those criteria, a sample of 2,785 Asian patients with depressive disorders was gathered from the REAP-AD3 study population: 264 older, 1,277 middle-aged, and 1,244 young adults.

Variables and data collection

REAP-AD3 data were collected through personal interviews and self-administered questionnaires by clinical coordinators at the research centers. The variables considered included age, sex, country, treatment setting (outpatient or inpatient), psychiatric diagnosis, and the use of psychotropic medications (antidepressants, antipsychotics, mood stabilizers, anxiolytics, or hypnotics). Depression and anxiety symptoms were evaluated using the Patient Health Questionnaire-9 (PHQ-9) [19] and Generalized Anxiety Disorder-7 (GAD-7) [20], respectively. Higher scores on the PHQ-9 and GAD-7 indicate greater severity of depression and anxiety symptoms. Both the PHQ-9 and GAD-7 have been formally translated into various Asian languages, and their reliability and validity are considered to be favorable [21-25].

The abbreviations for the PHQ-9 items are as follows: APE, poor appetite or overeating; CNC, trouble concentrating on things, such as reading the newspaper or watching television; DEP, feeling down, depressed, or hopeless; ENG, feeling tired or having little energy; HUR, thoughts that you would be better off dead or of hurting yourself in some way; INS, trouble falling or staying asleep, or sleeping too much; PLE, little interest or pleasure in doing things; SEL, feeling bad about yourself, or feeling that you are a failure or have let yourself or your family down; SLW, moving or speaking so slowly that others could have noticed, or the opposite—being so fidgety or restless that you have been moving around much more than usual. The abbreviations for the GAD-7 items are as follows: ANX, feeling nervous, anxious, or on edge; AWF, feeling afraid, as if something awful might happen; DFF, worrying too much about different things; IRR, becoming easily annoyed or irritable; RLX, trouble relaxing; RTL, being so restless that it is hard to sit still; and WOR, not being able to stop or control worrying.

Statistical analysis

To examine the network structure of depression and anxiety symptoms in older Asian patients with depressive disorders, the qgraph R package was used [26]. Network nodes (depression and anxiety symptoms) and edges (associations between symptoms) were constructed based on the PHQ-9 and GAD-7 item responses. The least absolute shrinkage and selection operator minimized false-positive edges, with very small edges set to zero [27]. The edges represent partial correlation coefficients, which reflect some symptom relationships while controlling for others. The extended Bayesian information criterion optimized the shrinkage parameter [28], and the Fruchterman-Reingold algorithm visualized the network structures by clustering related nodes [29]. The PHQ-9 and GAD-7 items were treated as ordered categorical variables, ranging from 0 to 4, with network estimation based on polychoric correlations. Community structures were assessed using the spin-glass algorithm from the igraph R package, which detects clusters based on edge strength and density [30]. Centrality metrics were calculated focusing on node strength (the sum of all edge weights), closeness (symptom integration), and betweenness (nodes acting as bridges). Stability was evaluated using bootstrapping, with correlation stability (CS) coefficients>0.250 (preferably >0.500), indicating robust results [31].

To compare the network structures of depression and anxiety symptoms across different age groups, this study used a network comparison test with 100 iterations via the Network-ComparisonTest package [32]. Structural and global strength invariance were tested, and Spearman’s correlation coefficients were used to assess differences in node centrality and edge weights, with p<0.05 considered significant (two-tailed). All statistical analyses were conducted using R 4.3.3 (R Foundation for Statistical Computing).

RESULTS

Sample description

As shown in Table 1, 9.5% (n=264) of the 2,785 study participants were classified as the older group. The average age of the older group was 68.4 years (standard deviation=16.4). The older group was characterized by a high proportion of outpatients (79.8%) and women (70.4%). Most of the older group was East Asian (43.5%) or Southeast Asian (31.0%). In addition, the group was prescribed with adjunctive use of antipsychotic (36.3%) and anxiolytic (47.0%) medications. As shown in Tables 2 and 3, the response frequency distributions indicate that the older group presented relatively lower scores on the individual PHQ-9 and GAD-7 items than the middle-aged and young adult groups.

General characteristics of older, middle-aged, and young adult Asian patients with depressive disorders

Frequency distribution of the Patient Health Questionnaire-9 items in older, middle-aged, and young adult Asian patients with depressive disorders

Frequency distribution of the Generalized Anxiety Disorder-7 items in older, middle-aged, and young adult Asian patients with depressive disorders

Network structure of depression and anxiety symptoms in older patients with depressive disorders

As shown in Figure 1A, 69 (57.5%) of the 120 possible edges were identified within the estimated network structure of depression and anxiety symptoms in the older group. All identified edges were estimated to be greater than 0. In terms of edge statistics, PLE-DEP (weight=0.487) had the most significant interconnection, followed by WOR-RLX (0.442), RLXRTL (0.356), CNC-SLW (0.276), APE-SEL (0.266), RTL-IRR (0.261), and INS-ENG (0.251). Those edges were assessed as favorable, with a CS coefficient of 0.441. In terms of node statistics, as illustrated in Supplementary Figure 1A, DEP was the most central node within the network, followed by RLX, WOR, ANX, RTL, and SEL, with INS being the least central. Node strength centrality demonstrated a meaningful level, with a CS coefficient of 0.281. The community detection method indicated that depression and anxiety symptoms were organized into two meaningful clusters. Cluster A consisted of PLE-DEP-INS-ENG-APE-SEL-CNE-SLW (i.e., depression symptom interconnection), and cluster B comprised HURANX-WOR-DFF-RLX-RTL-IRR-AWF (i.e., anxiety symptom interconnection). HUR was the only PHQ-9 item in cluster B.

Figure 1.

Network structures of depression and anxiety symptoms in Asian patients with depressive disorders. (A) Older (>65 years), (B) middle-aged (35–64 years), and (C) young adult (18–34 years). The green lines represent positive associations between the connecting nodes, and the red lines represent negative associations. The line thickness reflects the edge strength. The nodes represent depression and anxiety symptoms evaluated using the PHQ-9 and GAD-7, respectively. PHQ-9, Patient Health Questionnaire-9; GAD-7, Generalized Anxiety Disorder-7; APE, poor appetite or overeating (PHQ-9); ANX, feeling nervous, anxious, or on edge (GAD-7); AWF, feeling afraid, as if something awful might happen (GAD-7); CNC, trouble concentrating on things, such as reading the newspaper or watching television (PHQ-9); DFF, worrying too much about different things (GAD-7); DEP, feeling down, depressed, or hopeless (PHQ-9); ENG, feeling tired or having little energy (PHQ-9); HUR, thoughts that you would be better off dead or of hurting yourself in some way (PHQ-9); INS, trouble falling or staying asleep, or sleeping too much (PHQ-9); IRR, becoming easily annoyed or irritable (GAD-7); PLE, little interest or pleasure in doing things (PHQ-9); RLX, trouble relaxing (GAD-7); RTL, being so restless that it is hard to sit still (GAD-7); SEL, feeling bad about yourself, or feeling that you are a failure or have let yourself or your family down (PHQ-9); SLW, moving or speaking so slowly that others could have noticed, or the opposite—being so fidgety or restless that you have been moving around much more than usual (PHQ-9); WOR, not being able to stop or control worrying (GAD-7).

Network structures of depression and anxiety symptoms in middle-aged and young adult patients with depressive disorders

As shown in Figure 1B, 81 (67.5%) of the 120 potential edges were observed within the estimated network structure of depression and anxiety symptoms in the middle-aged group. Most of those edges were estimated to be greater than 0, with the exceptions of SEL-WOR (-0.010), INS-AWF (-0.048), ENGHUR (-0.055), and HUR-ANX (-0.061). In terms of edge statistics, PLE-DEP (weight=0.367) represented the most significant interconnection, followed by ANX-WOR (0.272), SLWHUR (0.257), and DEP-HUR (0.250). The edge was estimated to be at the highest level, with a CS coefficient of 0.750. Regarding node statistics, as illustrated in Supplementary Figure 1B, DEP was the node most centrally located within the network, followed by ANX, WOR, RLX, HUR, and RTL, and APE was the least central. Node strength centrality exhibited a favorable level, with a CS coefficient of 0.517. The community detection method indicated that the depression and anxiety symptoms were organized into two meaningful clusters. Cluster A contained PLE-DEP-INS-ENG-APE-SEL-CNESLW-HUR (representing the interconnection of depression symptoms), and cluster B encompassed ANX-WOR-DFFRLX-RTL-IRR-AWF (reflecting the interconnection of anxiety symptoms).

As shown in Figure 1C, 79 (65.8%) of the 120 possible edges were identified within the estimated network structure of depression and anxiety symptoms in the young adult group. Most of the identified edges were estimated to be greater than 0, with the exceptions of PEL-RTL (-0.010), ENG-SLW (-0.015), and DEP-RTL (-0.062). Regarding edge statistics, PLE-DEP (weight=0.423) represented the most significant interconnection, followed by SEL-HUR (0.329), WOR-DFF (0.322), ANX-WOR (0.283), and INS-APE (0.258). The edge with the highest estimate (PLE-DEP) was characterized by a CS coefficient of 0.750. In terms of node statistics, as illustrated in Supplementary Figure 1C, DEP was the node most centrally located within the network, followed by WOR, RTL, DFF, RLX, and ANX, with AWF being the least centrally located. Node strength centrality exhibited a favorable level, with a CS coefficient of 0.516. The community detection method indicated that the depression and anxiety symptoms were organized into two meaningful clusters. Cluster A contained PLEDEP-INS-ENG-APE-SEL-CNE-SLW-HUR (representing interconnections among depression symptoms), and cluster B consisted of ANX-WOR-DFF-RLX-RTL-IRR-AWF (representing interconnections among anxiety symptoms).

Comparing the network structures of older, middle-aged, and young adult patients with depressive disorders

As shown in Table 4, the comparison between older (Network 1) and middle-aged (Network 2) patients with depressive disorders revealed no significant differences in network structure invariance, network structure invariance with equal sample sizes, global strength invariance, or global strength invariance with equal sample sizes. Spearman correlations of node strength centrality and edges indicated a strong correlation (0.83) and a very strong correlation (0.94), respectively. Similarly, the comparison between older (Network 1) and young adult (Network 3) patients with depressive disorders demonstrated no significant differences in terms of network structure invariance, network structure invariance with equal sample sizes, and global strength invariance with equal sample sizes. However, a significant difference was found in the global strength invariance between the two network structures (pvalue=0.01). Spearman correlations of node strength centrality and edges indicated a strong correlation (0.74) and a very strong correlation (0.92), respectively.

Pairwise comparison of the networks of depression and anxiety symptoms among older, middle-aged, and young adult Asian patients with depressive disorders

Lastly, as shown in Figure 2A, the network structure of anxiety and depression symptoms was estimated using data from all age groups to visualize the similarities and differences in the edge connections across groups. This network analysis of GAD-7 and PHQ-9 items revealed that 83 (69.1%) of the 120 possible edges had an estimated weight greater than zero. Several strong interconnections were identified in the network, particularly the following item pairs: PLE-DEP (0.429), WORDFF (0.282), ANX-WOR (0.273), SEL-HUR (0.250), INS-ENG (0.229), RLX-RTL (0.227), and WOR-RLX (0.222). Edge statistics indicated a high level of interpretability, with a CS coefficient of 0.750. As shown in Figure 2B, the node strength centrality analysis showed that DEP was the most central symptom, followed by WOR, ANX, RLX, HUR, and RTL. In contrast, RTL was the least interconnected symptom in the network, followed by APE, AWF, IRR, and CNC. The node statistics indicated a high level of interpretability, with a CS coefficient of 0.750.

Figure 2.

Network analysis of depression and anxiety symptoms in the cross-sample data set combining the three groups. A: Network structure of depression and anxiety symptoms. B: Node-strength centrality. The green lines represent positive associations between the connecting nodes, and the red lines represent negative associations. The line thickness reflects the edge strength. The nodes represent depression and anxiety symptoms evaluated using the PHQ-9 and GAD-7, respectively. PHQ-9, Patient Health Questionnaire-9; GAD-7, Generalized Anxiety Disorder-7; APE, poor appetite or overeating (PHQ-9); ANX, feeling nervous, anxious, or on edge (GAD-7); AWF, feeling afraid, as if something awful might happen (GAD-7); CNC, trouble concentrating on things, such as reading the newspaper or watching television (PHQ-9); DFF, worrying too much about different things (GAD-7); DEP, feeling down, depressed, or hopeless (PHQ-9); ENG, feeling tired or having little energy (PHQ-9); HUR, thoughts that you would be better off dead or of hurting yourself in some way (PHQ-9); INS, trouble falling or staying asleep, or sleeping too much (PHQ-9); IRR, becoming easily annoyed or irritable (GAD-7); PLE, little interest or pleasure in doing things (PHQ-9); RLX, trouble relaxing (GAD-7); RTL, being so restless that it is hard to sit still (GAD-7); SEL, feeling bad about yourself, or feeling that you are a failure or have let yourself or your family down (PHQ-9); SLW, moving or speaking so slowly that others could have noticed, or the opposite—being so fidgety or restless that you have been moving around much more than usual (PHQ-9); WOR, not being able to stop or control worrying (GAD-7).

DISCUSSION

This study found no significant differences in the network structure of anxiety and depression symptoms across adult age groups, although the symptom severities varied with age in patients with depressive disorders. Although the symptom network structures are consistent, subtle differences are present, particularly in the interconnection and expression of symp-toms. Lamers et al. [33] used a factor analysis and demonstrated that the structure of depression in adolescents is similar to the structure in adults. Those findings, combined with ours, support the use of age-neutral diagnostic frameworks that accommodate both shared and age-specific symptom interconnections while minimizing the impact of ageist biases. An ageneutral diagnostic framework would focus on identifying and evaluating symptoms based on their intrinsic characteristics, rather than relying on assumptions or stereotypes about how symptoms typically manifest in different age groups. Advanc-ing equitable and inclusive integrative care for depressive disorder is needed due to consistent symptomatic patterns [34-36]. In older adults, ageism can lead to the misinterpretation of depressive disorders as a natural part of aging because depressive symptoms can manifest as physical complaints [37]. In addition, the findings of this study can be discussed as follows. First, the findings reported here challenge ageist assumptions that age is a primary influence on clinical presentation, which reinforce biases in treatment priorities. The subtle differences observed in global strength and symptom connectivity indicate that depression and anxiety manifest in consistently interconnected ways throughout the lifespan. In our findings, the strong centrality of depressive mood and its connections to worry and restlessness across age groups highlight that treatment approaches should target shared symptom nodes regardless of the patient’s age. Second, against the ageist tendency to over- or under-pathologize certain age groups, our findings advocate for a more inclusive perspective when providing mental health care for depressive disorders. Ageism often manifests as exaggerated distinctions between younger and older adults, and it frequently leads to the marginalization of older populations in clinical trials and the allocation of resources [10-12,38]. By demonstrating the structural similarity of depression and anxiety symptom networks across age groups, this study should prompt a paradigm shift toward age-neutral diagnostic and therapeutic strategies to protect older adults with depressive disorders against ageist biases. Third, although symptom networks are similar across age groups, the causes of anxiety and depression might differ by age. In older adults, the strong interconnection between insomnia and fatigue could be causatively associated with physical illness and social isolation [39]. Contrastingly, in middle-aged adults, the strong interconnection between depressive mood and excessive worry could be caused by workplace stress and family caregiving burden [40], and in young adults, the strong interconnection between anxiety and self-criticism could be caused by economic insecurity, social comparison, and interpersonal stress [41]. Therefore, individualized approaches might be needed to prevent age-related biases when treating depressive disorders.

The network structure of depression and anxiety symptoms in older patients presents relatively strong interconnections among somatic symptoms (i.e., insomnia-energy), core depressive symptoms (e.g., loss of interest or pleasure-depressive mood), and anxiety-related symptoms (e.g., worry-restlessness). These findings can contribute to a reconsideration of ageist stereotypes that often marginalize older adults as frail and cognitively declining. The identification of depressive mood as the most central symptom highlights its pivotal role in the symptom network of older patients, emphasizing its potential as a primary therapeutic target. In addition, this finding can be discussed as follows. Unlike depression in young adulthood, late-life depression can be categorized based on differences in structural neuroimaging, distinct clinical features, genetic patterns, and susceptibility to future neurodegenerative diseases [42]. In addition, repeated depressive episodes can be associated with an acceleration of biological aging [43]. This perspective suggests that the core symptomatic phenomenon of depression resides in feelings of hopelessness, whereas age-related variations (i.e., pronounced cognitive decline, prominent physical symptoms) in older adults might represent unique characteristics of depressive disorders in that age group. On the other hand, the young adult group presented subtly different findings, including a relatively strong interconnection between selfcriticism and self-hurting. That finding might be explained by the unstable job security more often found in younger individuals than older adults [44]. The economic insecurity and social isolation associated with unstable job security could also contribute to the heightened risk of suicide in the young adult group [45]. Moreover, it is speculated that the biological interaction of aging and accelerating aging associated with depressive disorders present differently by age. In young adults, energy depletion can contribute to functional decline, which is associated with social vulnerability and can exacerbate job security and worsen economic conditions. Also, depressed young adults tend to feel more deprived and isolated than their nondepressed peers. Thus, these biological and social factors might explain the subtle variations found in symptom networks across age groups [43].

Our study has several limitations. First, the cross-sectional design limits our ability to infer causality or temporal changes in symptom networks. Longitudinal studies are required to examine how symptom interconnections evolve. Second, reliance on self-report measures could introduce response bias, particularly among older adults who might underreport emotional symptoms because of cultural or generational attitudes toward mental health. Third, variations in the sample size across age groups and countries might influence the generalizability of our findings. Further research is needed to investigate whether interventions targeting shared central symptoms, including depressive mood and excessive worry, can mitigate the effects of ageist biases in mental health care [46]. Fourth, PHQ-9 and GAD-7 might lack the sensitivity needed to capture age-specific psychiatric manifestations and the potential influence of cultural and generational factors on symptom reporting. Fifth, depression and anxiety symptom networks might vary across cultural and racial contexts, influencing symptom clustering and connectivity patterns. To enhance the generalizability of these findings, further study to examine whether similar network structures emerge in Western older adults might be needed. Comparing cross-cultural symptom networks could clarify whether these interconnections reflect universal aging-related mechanisms or culture-specific expressions of depression and thus inform more targeted diagnostic and therapeutic approaches. Sixth, anxiety/depression symptoms and other psychiatric conditions have potential overlap, and that might have influenced our findings. Lastly, the influence of antidepressants on symptom expression should be considered because both anxiety and depression symptoms can be alleviated by antidepressants such as selective serotonin reuptake inhibitors [47].

Despite those limitations, our network analysis has challenged ageist stereotypes about depressive disorders. Our study highlights the relatively consistent interconnection of depression and anxiety symptoms across different age groups, although the symptom severities vary with age. By identifying potentially central symptoms and advocating for inclusive and equitable mental health care, this study contributes to the growing movement to advance age-neutral approaches to the diagnosis and treatment of depressive disorders.

Supplementary Materials

The Supplement is available with this article at https://doi.org/10.30773/pi.2025.0033.

Supplementary Figure 1.

Node strength centralities of depression and anxiety symptoms in Asian patients with depressive disorders. (A) older (>65 years), (B) middle-aged (35–64 years), and (C) young adult (18–34 years). PHQ-9, Patient Health Questionnaire-9; GAD-7, Generalized Anxiety Disorder-7; APE, poor appetite or overeating (PHQ-9); ANX, feeling nervous, anxious, or on edge (GAD-7); AWF, feeling afraid, as if something awful might happen (GAD-7); CNC, trouble concentrating on things, such as reading the newspaper or watching television (PHQ-9); DFF, worrying too much about different things (GAD-7); DEP, feeling down, depressed, or hopeless (PHQ-9); ENG, feeling tired or having little energy (PHQ-9); HUR, thoughts that you would be better off dead or of hurting yourself in some way (PHQ-9); INS, trouble falling or staying asleep, or sleeping too much (PHQ-9); IRR, becoming easily annoyed or irritable (GAD-7); PLE, little interest or pleasure in doing things (PHQ-9); RLX, trouble relaxing (GAD-7); RTL, being so restless that it is hard to sit still (GAD-7); SEL, feeling bad about yourself, or feeling that you are a failure or have let yourself or your family down (PHQ-9); SLW, moving or speaking so slowly that others could have noticed, or the opposite—being so fidgety or restless that you have been moving around much more than usual (PHQ-9); WOR, not being able to stop or control worrying (GAD-7).

pi-2025-0033-Supplementary-Fig-1.pdf

Notes

Availability of Data and Material

The datasets generated or analyzed during the study are not publicly available because of institutional ownership, but they are available from the corresponding author upon reasonable request.

Conflicts of Interest

Seon-Cheol Park and Norman Sartorius, contributing editors of Psychiatry Investigation, were not involved in the editorial evaluation or decision to publish this article. All remaining authors have declared no conflicts of interest.

Author Contributions

Conceptualization: Seon-Cheol Park, Afzal Javed, Kang Sim, Shih-Ku Lin, Takahiro A. Kato, Naotaka Shinfuku, Norman Sartorius. Data curation: Seon-Cheol Park, Seungwon Cho, Tian-Mei Si, Roy Abraham Kallivayalil, Andi J. Tanra, Amir Hossein Jalali Nadoushan, Kok Yoon Chee, Afzal Javed, Kang Sim, Pornjira Pariwatcharakul, Shih-Ku Lin, Takahiro A. Kato. Formal analysis: Seon-Cheol Park, Kiwon Kim, Jeongsoo Park, Sun Choi, Seonhwa Lee, Eunkyung Kim. Investigation: Seon-Cheol Park, Seungwon Cho. Resources: Seon-Cheol Park, Tian-Mei Si, Roy Abraham Kallivayalil, Andi J. Tanra, Amir Hossein Jalali Nadoushan, Kok Yoon Chee, Afzal Javed, Kang Sim, Pornjira Pariwatcharakul, Shih-Ku Lin, Takahiro A. Kato. Supervision: Afzal Javed, Kang Sim, Shih-Ku Lin, Takahiro A. Kato, Naotaka Shinfuku, Norman Sartorius. Validation: Seon-Cheol Park. Visualization: Seon-Cheol Park. Writing—original draft: Seon-Cheol Park. Writing—review & editing: Seon-Cheol Park, Kiwon Kim, Jeongsoo Park, Sun Choi, Seonhwa Lee, Eunkyung Kim.

Funding Statement

This research has been supported by the AMOREPACIFIC Foundation.

Acknowledgments

We would like to thank Dr. Jinseob Kim for his valuable help with the network analysis.

References

1. Jo S, Han KD, Yoo J, Shin DW, Kim H, Jeon HJ. Abdominal obesity increases the risk for depression by sex: a nationwide cohort study in South Korea. Psychiatry Investig 2024;21:1398–1406.
2. Jung E, Ryu HH, Ryu SJ. Effect of the interaction between depression and sleep disorders on stroke occurrence: a 17-year prospective cohort study in Korea. Psychiatry Investig 2024;21:1391–1397.
3. Moon JY, Kim SY, Yang S, Yoon S. Validity and reliability of the Korean version of Gotland Male Depression Scale. Psychiatry Investig 2025;22:102–109.
4. Lichtenberg P, Belmaker RH. Subtyping major depressive disorder. Psychother Psychosom 2010;79:131–135.
5. Husain MM, Rush AJ, Sackeim HA, Wisniewski SR, McClintock SM, Craven N, et al. Age-related characteristics of depression: a preliminary STAR*D report. Am J Geriatr Psychiatry 2005;13:852–860.
6. Gatz M, Hurwicz ML. Are old people more depressed? Cross-sectional data on Center for Epidemiological Studies Depression Scale factors. Psychol Aging 1990;5:284–290.
7. Goldberg JH, Breckenridge JN, Sheikh JI. Age differences in symptoms of depression and anxiety: examining behavioral medicine outpatients. J Behav Med 2003;26:119–132.
8. Maes M. Effects of age and gender on the classification and phenomenology of unipolar depression. Acta Neuropsychiatr 2002;14:29–35.
9. Wilkowska-Chmielewska J, Szelenberger W, Wojnar M. Age-dependent symptomatology of depression in hospitalized patients and its implications for DSM-5. J Affect Disord 2013;150:142–145.
10. World Health Organization. Global action plan on the public health response to dementia 2017–2025. Geneva: World Health Organization; 2017.
11. World Health Organization. Global campaign to combat ageism: Toolkit. Geneva: World Health Organization; 2021.
12. World Health Organization. Global report on ageism. Geneva: World Health Organization; 2021.
13. Stanford W, Mucha PJ, Dayan E. Age-related differences in network controllability are mitigated by redundancy in large-scale brain networks. Commun Biol 2024;7:701.
14. Park SC, Kim D. The centrality of depressive and anxiety symptoms in major depressive disorder determined using a network analysis. J Affect Disord 2020;271:19–26.
15. Park SC, Shinfuku N, Maramis MM, Lee MS, Park YC. Adjunctive antipsychotic prescriptions for outpatients with depressive disorders in Asia: The Research on Asian Psychotropic Prescription Patterns for Antidepressants (REAP-AD) study. Am J Psychiatry 2015;172:684–685.
16. Park SC, Jang EY, Xiang YT, Kanba S, Kato TA, Chong MY, et al. Network analysis of the depressive symptom profiles in Asian patients with depressive disorders: findings from the Research on Asian Psychotropic Prescription Patterns for Antidepressants (REAP-AD). Psychiatry Clin Neurosci 2020;74:344–353.
17. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.
18. World Health Organization. Anatomical therapeutic chemical (ATC) classification system [Internet]. Available at: https://www.who.int/tools/atc-ddd-toolkit/atc-classification. Accessed January 1, 2025.
19. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA 1999;282:1737–1744.
20. Sapra A, Bhandari P, Sharma S, Chanpura T, Lopp L. Using Generalized Anxiety Disorder-2 (GAD-2) and GAD-7 in a primary care setting. Cureus 2020;12e8224.
21. He X, Li C, Qian J, Cui H, Wu WY. Reliability and validity of a generalized anxiety disorder scale in general hospital outpatients. Shanghai Arch Psychiatry 2010;22:200–203.
22. Lee SH, Shin C, Kim H, Jeon SW, Yoon HK, Ko YH, et al. Validation of the Korean version of the Generalized Anxiety Disorder 7 self-rating scale. Asia Pac Psychiatry 2022;14e12421.
23. Muramatsu K, Miyaoka H, Kamijima K, Muramatsu Y, Tanaka Y, Hosaka M, et al. Performance of the Japanese version of the Patient Health Questionnaire-9 (J-PHQ-9) for depression in primary care. Gen Hosp Psychiatry 2018;52:64–69.
24. Park SJ, Choi HR, Choi JH, Kim K, Hong JP. Reliability and validity of the Korean Version of the Patient Health Questionnaire-9 (PHQ-9). Anxiety Mood 2010;6:119–124.
25. Wang W, Bian Q, Zhao Y, Li X, Wang W, Du J, et al. Reliability and validity of the Chinese version of the Patient Health Questionnaire (PHQ-9) in the general population. Gen Hosp Psychiatry 2014;36:539–544.
26. Epskamp S, Cramer AO, Waldorp LJ, Schmittmann VD, Borsboom D. qgraph: network visualizations of relationships in psychometric data. J Stat Softw 2012;48:1–18.
27. Tibshirani R. Regression shrinkage and selection via the Lasso. J R Stat Soc Ser B Stat Methodol 1996;58:267–288.
28. Chen J, Chen Z. Extended Bayesian information criteria for model selection with large model spaces. Biometrika 2008;95:759–771.
29. Csárdi G, Nepusz T. The igraph software package for complex network research. InterJournal 2006;Complex Systems:1695.
30. Opsahl T, Agneessens F, Skvoretz J. Node centrality in weighted networks: generalizing degree and shortest paths. Soc Networks 2010;32:245–251.
31. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. New York: Routledge; 2013.
32. van Borkulo CD, van Bork R, Boschloo L, Kossakowski JJ, Tio P, Schoevers RA, et al. Comparing network structures on three aspects: a permutation test. Psychol Methods 2023;28:1273–1285.
33. Lamers F, Burstein M, He JP, Avenevoli S, Angst J, Merikangas KR. Structure of major depressive disorder in adolescents and adults in the US general population. Br J Psychiatry 2012;201:143–150.
34. Facon MF, van Alphen SPJ, Dierckx E, Rossi G. Age-neutral measurement of personality functioning and maladaptive personality traits. Assessment 2025;32:3–13.
35. Debast I, Rossi G, van Alphen SPJ. Age-neutrality of a brief assessment of the section III alternative model for personality disorders in older adults. Assessment 2018;25:310–323.
36. Pauwels E, Claes L, Dierckx E, Debast I, Van Alphen SP, Rossi G, et al. Age neutrality of the Young Schema Questionnaire in patients with a substance use disorder. Int Psychogeriatr 2014;26:1317–1326.
37. Unützer J, Katon W, Callahan CM, Williams JW Jr, Hunkeler E, Harpole L, et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA 2002;288:2836–2245.
38. Evans IEM, Llewellyn DJ, Matthews FE, Woods RT, Brayne C, Clare L, ; CFAS-Wales research team. Social isolation, cognitive reserve, and cognition in healthy older people. PLoS One 2018;13e0201008.
39. Albalak G, Noordam R, van der Elst M, Kervezee L, Exadaktylos V, van Bodegom D, et al. Older adults exercising ON TIME: protocol for a randomized controlled cross-over study to assess the effect of physical activity timing on insomnia severity. Trials 2024;25:523.
40. Spiegler G, Su Y, Li M, Wolfson C, Meng X, Schmitz N. Characterization of depression subtypes and their relationships to stressor profiles among middle-aged and older adults: An analysis of the canadian longitudinal study on aging (CLSA). J Psychiatr Res 2024;175:333–342.
41. Tsai CC, Yang YK, Cheng CH. The effect of social comparison with peers on self-evaluation. Psychol Rep 2014;115:526–536.
42. Wen J, Fu CHY, Tosun D, Veturi Y, Yang Z, Abdulkadir A, et al. Characterizing heterogeneity in neuroimaging, cognition, clinical symptoms, and genetics among patients with late-life depression. JAMA Psychiatry 2022;79:464–474.
43. Szymkowicz SM, Gerlach AR, Homiack D, Taylor WD. Biological factors influencing depression in later life: role of aging processes and treatment implications. Transl Psychiatry 2023;13:160.
44. Seo HJ, Song HR, Yim HW, Kim JB, Lee MS, Kim JM, et al. Age-related differences in suicidality between young people and older adults with depression: data from a nationwide depression cohort study in Korea (the CRESCEND study). Compr Psychiatry 2015;56:85–92.
45. Norström T, Grönqvist H. The great recession, unemployment and suicide. J Epidemiol Community Health 2014;69:110–116.
46. Bodner E, Palgi Y, Wyman MF. Ageism in mental health assessment and treatment of older adults. In: Ayalon L, Tesch-Römer C, editors. Contemporary Perspectives on Ageism. Cham: Springer; 2018. p.265- 282.
47. Deshauer D, Moher D, Fergusson D, Moher E, Sampson M, Grimshaw J. Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials. CMAJ 2008;178:1293–1301.

Article information Continued

Figure 1.

Network structures of depression and anxiety symptoms in Asian patients with depressive disorders. (A) Older (>65 years), (B) middle-aged (35–64 years), and (C) young adult (18–34 years). The green lines represent positive associations between the connecting nodes, and the red lines represent negative associations. The line thickness reflects the edge strength. The nodes represent depression and anxiety symptoms evaluated using the PHQ-9 and GAD-7, respectively. PHQ-9, Patient Health Questionnaire-9; GAD-7, Generalized Anxiety Disorder-7; APE, poor appetite or overeating (PHQ-9); ANX, feeling nervous, anxious, or on edge (GAD-7); AWF, feeling afraid, as if something awful might happen (GAD-7); CNC, trouble concentrating on things, such as reading the newspaper or watching television (PHQ-9); DFF, worrying too much about different things (GAD-7); DEP, feeling down, depressed, or hopeless (PHQ-9); ENG, feeling tired or having little energy (PHQ-9); HUR, thoughts that you would be better off dead or of hurting yourself in some way (PHQ-9); INS, trouble falling or staying asleep, or sleeping too much (PHQ-9); IRR, becoming easily annoyed or irritable (GAD-7); PLE, little interest or pleasure in doing things (PHQ-9); RLX, trouble relaxing (GAD-7); RTL, being so restless that it is hard to sit still (GAD-7); SEL, feeling bad about yourself, or feeling that you are a failure or have let yourself or your family down (PHQ-9); SLW, moving or speaking so slowly that others could have noticed, or the opposite—being so fidgety or restless that you have been moving around much more than usual (PHQ-9); WOR, not being able to stop or control worrying (GAD-7).

Figure 2.

Network analysis of depression and anxiety symptoms in the cross-sample data set combining the three groups. A: Network structure of depression and anxiety symptoms. B: Node-strength centrality. The green lines represent positive associations between the connecting nodes, and the red lines represent negative associations. The line thickness reflects the edge strength. The nodes represent depression and anxiety symptoms evaluated using the PHQ-9 and GAD-7, respectively. PHQ-9, Patient Health Questionnaire-9; GAD-7, Generalized Anxiety Disorder-7; APE, poor appetite or overeating (PHQ-9); ANX, feeling nervous, anxious, or on edge (GAD-7); AWF, feeling afraid, as if something awful might happen (GAD-7); CNC, trouble concentrating on things, such as reading the newspaper or watching television (PHQ-9); DFF, worrying too much about different things (GAD-7); DEP, feeling down, depressed, or hopeless (PHQ-9); ENG, feeling tired or having little energy (PHQ-9); HUR, thoughts that you would be better off dead or of hurting yourself in some way (PHQ-9); INS, trouble falling or staying asleep, or sleeping too much (PHQ-9); IRR, becoming easily annoyed or irritable (GAD-7); PLE, little interest or pleasure in doing things (PHQ-9); RLX, trouble relaxing (GAD-7); RTL, being so restless that it is hard to sit still (GAD-7); SEL, feeling bad about yourself, or feeling that you are a failure or have let yourself or your family down (PHQ-9); SLW, moving or speaking so slowly that others could have noticed, or the opposite—being so fidgety or restless that you have been moving around much more than usual (PHQ-9); WOR, not being able to stop or control worrying (GAD-7).

Table 1.

General characteristics of older, middle-aged, and young adult Asian patients with depressive disorders

Total sample (N=2,785) Older (>65 yr) (N=264) Middle-aged (35–64 yr) (N=1,277) Young adult (18–34 yr) (N=1,244)
Age (yr) 41.9±15.9 68.4±16.3 49.3±15.7 28.7±16.1
Women 1,822 (65.4) 186 (70.4) 832 (65.2) 804 (64.6)
Country
 China 388 (13.9) 34 (12.9) 196 (15.3) 158 (12.7)
 India 175 (6.3) 7 (2.7) 89 (7.0) 79 (6.4)
 Indonesia 350 (12.6) 16 (6.1) 169 (13.2) 165 (13.2)
 Iran 155 (5.6) 9 (3.4) 63 (4.9) 83 (6.7)
 Japan 214 (7.7) 24 (9.1) 112 (8.8) 78 (6.3)
 Korea 197 (7.1) 21 (8.0) 79 (6.2) 97 (7.8)
 Malaysia 286 (10.2) 14 (4.9) 117 (9.2) 155 (12.4)
 Pakistan 399 (14.3) 51 (19.3) 180 (1.4) 168 (13.5)
 Singapore 44 (1.6) 5 (1.9) 20 (1.6) 19 (1.5)
 Taiwan 256 (9.2) 36 (13.6) 115 (9.0) 105 (8.4)
 Thailand 322 (11.6) 48 (18.2) 137 (10.7) 137 (11.0)
Country by region
 East Asia 1,055 (37.9) 115 (43.5) 502 (39.3) 438 (35.2)
 South Asia 547 (19.6) 58 (22.0) 269 (21.1) 247 (19.9)
 Southeast Asia 1,002 (35.9) 83 (31.0) 443 (34.7) 476 (38.3)
 West Asia 155 (5.6) 9 (3.5) 63 (4.9) 83 (6.7)
Outpatient 2,105 (75.6) 211 (79.8) 976 (76.4) 918 (73.8)
Psychotropic medication
 Antipsychotic 897 (32.0) 96 (36.3) 432 (33.8) 369 (29.7)
 Mood stabilizer 169 (6.1) 19 (7.2) 74 (5.8) 76 (6.1)
 Anxiolytic 892 (32.0) 124 (47.0) 543 (42.5) 225 (18.0)
 Hypnotic 481 (17.3) 79 (29.9) 285 (22.3) 117 (9.4)

Values are presented as mean±standard deviation or number (%)

Table 2.

Frequency distribution of the Patient Health Questionnaire-9 items in older, middle-aged, and young adult Asian patients with depressive disorders

Total sample (N=2,785) Older (>65 yr) (N=264) Middle-aged (35–64 yr) (N=1,277) Young adult (18–34 yr) (N=1,244)
PLE
 0 553 (19.8) 95 (35.9) 274 (21.5) 183 (14.7)
 1 897 (32.2) 75 (28.4) 454 (35.6) 368 (29.6)
 2 730 (26.3) 38 (14.4) 307 (24.0) 384 (30.9)
 3 605 (21.7) 56 (21.2) 240 (18.8) 309 (24.8)
DEP
 0 562 (20.2) 90 (34.1) 265 (20.8) 207 (16.6)
 1 880 (31.6) 73 (27.7) 533 (41.7) 274 (22.0)
 2 716 (25.7) 44 (16.7) 265 (20.8) 407 (32.7)
 3 627 (22.5) 57 (21.6) 214 (16.7) 356 (28.6)
INS
 0 568 (20.3) 82 (31.1) 280 (21.9) 206 (16.6)
 1 856 (30.7) 76 (28.8) 402 (31.5) 378 (30.4)
 2 605 (21.7) 43 (16.3) 258 (20.2) 304 (24.4)
 3 756 (27.3) 63 (23.9) 337 (26.4) 356 (28.6)
ENG
 0 537 (18.3) 88 (33.3) 265 (20.8) 184 (14.8)
 1 932 (32.0) 84 (31.8) 419 (32.8) 429 (34.5)
 2 694 (28.4) 49 (18.6) 313 (24.5) 332 (26.7)
 3 622 (21.3) 43 (16.2) 280 (21.9) 299 (24.0)
APE
 0 809 (29.0) 122 (46.2) 389 (30.5) 298 (24.0)
 1 815 (29.3) 68 (25.8) 386 (30.2) 361 (29.0)
 2 632 (22.7) 35 (13.3) 278 (21.8) 319 (25.6)
 3 529 (19.0) 39 (14.7) 224 (17.5) 266 (21.4)
SEL
 0 743 (26.7) 136 (51.5) 337 (26.4) 270 (21.7)
 1 851 (30.6) 49 (18.5) 429 (33.6) 373 (30.0)
 2 633 (22.7) 45 (17.0) 280 (21.9) 308 (24.8)
 3 558 (20.0) 34 (12.9) 231 (18.1) 293 (23.6)
CNC
 0 820 (29.4) 136 (51.5) 364 (28.5) 320 (25.7)
 1 863 (31.0) 59 (22.4) 409 (32.0) 395 (31.8)
 2 659 (23.7) 42 (15.9) 310 (24.3) 307 (24.7)
 3 443 (15.9) 27 (10.2) 194 (15.2) 222 (17.8)
SLW
 0 1,100 (39.3) 134 (50.8) 550 (43.1) 416 (33.4)
 1 804 (28.7) 59 (22.3) 377 (29.5) 368 (29.6)
 2 478 (17.0) 41 (15.5) 169 (13.2) 268 (21.5)
 3 423 (15.0) 30 (11.3) 201 (15.7) 192 (15.5)
HUR
 0 1,412 (50.7) 189 (71.6) 718 (56.2) 505 (40.6)
 1 657 (23.6) 33 (12.5) 307 (24.0) 317 (25.5)
 2 424 (15.2) 24 (9.1) 165 (12.9) 235 (18.9)
 3 292 (10.5) 18 (6.8) 87 (6.8) 187 (15.0)

Values are presented as number (%). APE, poor appetite or overeating; CNC, trouble concentrating on things, such as reading the newspaper or watching television; DEP, feeling down, depressed, or hopeless; ENG, feeling tired or having little energy; HUR, thoughts that you would be better off dead or of hurting yourself in some way; INS, trouble falling or staying asleep, or sleeping too much; PLE, little interest or pleasure in doing things; SEL, feeling bad about yourself, or feeling that you are a failure or have let yourself or your family down; SLW, moving or speaking so slowly that others could have noticed, or the opposite—being so fidgety or restless that you have been moving around much more than usual

Table 3.

Frequency distribution of the Generalized Anxiety Disorder-7 items in older, middle-aged, and young adult Asian patients with depressive disorders

Total sample (N=2,785) Older (>65 yr) (N=264) Middle-aged (35–64 yr) (N=1,277) Young adult (18–34 yr) (N=1,244)
ANX
 0 597 (21.4) 93 (35.3) 291 (22.8) 213 (17.1)
 1 1,063 (38.2) 89 (33.7) 494 (38.7) 480 (38.6)
 2 623 (22.4) 37 (14.0) 277 (21.7) 309 (24.8)
 3 502 (18.0) 45 (17.0) 215 (16.8) 242 (19.5)
WOR
 0 801 (28.8) 120 (45.4) 403 (31.6) 278 (22.3)
 1 948 (34.0) 56 (21.2) 453 (35.5) 439 (35.3)
 2 591 (21.2) 44 (16.7) 243 (19.0) 304 (24.4)
 3 445 (16.0) 44 (16.7) 178 (13.9) 223 (17.9)
DFF
 0 625 (22.4) 84 (31.8) 291 (22.8) 250 (20.1)
 1 924 (33.2) 98 (37.1) 419 (32.8) 407 (32.7)
 2 568 (20.4) 43 (16.3) 233 (18.2) 292 (23.5)
 3 669 (24.0) 39 (14.8) 335 (26.2) 295 (23.7)
RLX
 0 831 (29.8) 113 (42.9) 410 (32.1) 308 (24.8)
 1 904 (32.5) 78 (29.5) 410 (32.1) 416 (33.4)
 2 569 (20.4) 33 (12.5) 244 (19.1) 292 (23.5)
 3 482 (17.3) 40 (15.1) 213 (16.7) 229 (18.4)
RTL
 0 1,236 (44.3) 170 (64.4) 613 (48.0) 453 (36.4)
 1 776 (27.9) 51 (19.3) 329 (25.8) 396 (31.8)
 2 460 (16.5) 21 (8.0) 203 (15.9) 236 (19.0)
 3 314 (11.3) 22 (8.3) 132 (10.3) 160 (12.9)
IRR
 0 816 (30.0) 115 (43.6) 410 (32.1) 291 (23.3)
 1 934 (34.5) 91 (34.5) 430 (33.7) 413 (33.2)
 2 477 (18.1) 28 (10.6) 253 (19.8) 296 (23.8)
 3 458 (17.4) 30 (11.4) 184 (14.4) 244 (19.6)
AWF
 0 987 (35.5) 124 (47.0) 501 (39.2) 362 (29.1)
 1 849 (30.5) 84 (31.8) 385 (30.2) 380 (30.5)
 2 527 (18.9) 31 (11.7) 233 (18.2) 263 (21.1)
 3 422 (15.1) 25 (9.5) 158 (12.4) 239 (19.2)

Values are presented as number (%). ANX, feeling nervous, anxious, or on edge; AWF, feeling afraid, as if something awful might happen; DFF, worrying too much about different things; IRR, becoming easily annoyed or irritable; RLX, trouble relaxing; RTL, being so restless that it is hard to sit still; WOR, not being able to stop or control worrying

Table 4.

Pairwise comparison of the networks of depression and anxiety symptoms among older, middle-aged, and young adult Asian patients with depressive disorders

Network 1 vs. 2 Network 1 vs. 3
NCT: network structure invariance (p-value) 0.85 0.39
NCT: network structure invariance-equal sample sizes (mean p-value) 0.54 0.54
NCT: global strength invariance (p-value) 0.18 0.01
NCT: global strength invariance-equal sample sizes (mean p-value) 0.49 0.24
Significantly different edges in the individual edge invariance test 10 (8.3) 13 (10.8)
Spearman correlation: Node strength centrality 0.83 0.74
Spearman correlation: Edges 0.94 0.92
Rank-order differences=0 67 (55.3) 69 (57.1)

Values are presented as number only or number (%). Network 1, older; Network 2, middle-aged; Network 3, young adult; NCT, Network-ComparisonTest